Based on reports that VANGL2 upregulation is associated with higher-grade breast tumors [31], we hypothesize that elevated VANGL2 expression and resulting activation of Wnt/PCP signaling is a feature of late-stage or advanced disease. The gene discussed is VANGL2; the disease is breast neoplasm.